PUMA BIOTECHNOLOGY INC shareholders Q1 2023

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

PUMA BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
MACQUARIE GROUP LTD 61,255$189,0000.00%
Citadel Advisors 15,200$46,9680.00%
Citadel Advisors 9,000$27,8100.00%
Citadel Advisors 236,375$730,3990.00%
ROYAL BANK OF CANADA 385$1,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 45,100$139,3590.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 36,100$111,5490.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 462,196$1,428,1860.00%
COMMONWEALTH EQUITY SERVICES, LLC 10,749$330.00%
SIMPLEX TRADING, LLC 10,367$320.00%
BARCLAYS PLC 17,298$540.00%
JPMORGAN CHASE & CO 1,103$3,0000.00%
TUCKER ASSET MANAGEMENT LLC 126$3890.00%
Geneos Wealth Management Inc. 1,000$3,0900.00%
BNP PARIBAS FINANCIAL MARKETS 242$7480.00%
Squarepoint Ops LLC 16,850$52,0660.00%
Tower Research Capital LLC (TRC) 4,853$150.00%
OSAIC HOLDINGS, INC. 16,941$49,6660.00%
FMR LLC 127,842$395,0320.00%
DIMENSIONAL FUND ADVISORS LP 453,105$1,400,0950.00%
External links

This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q1 2023. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.